Processa Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Revenue	0	0	0	0	0	0	0	0	0.11	0.11	Upgrade
Revenue Growth (YoY)	-	-	-	-	-	-	-	-	5.77%	-65.68%	Upgrade
Cost of Revenue	0	0	0	0	0	0	0	0	0.13	0.07	Upgrade
Gross Profit	0	0	0	0	0	0	0	0	-0.01	0.04	Upgrade
Selling, General & Admin	5.66	8.76	4.69	3.26	1.61	1.44	0.84	0	0.95	2.02	Upgrade
Research & Development	5.8	11.49	6.88	3.17	2.32	3.09	0.96	0	0.03	0.18	Upgrade
Other Operating Expenses	0	7.27	0.57	8.7	0	0	0	1.92	1.7	0.39	Upgrade
Operating Expenses	11.46	27.53	12.13	15.14	3.94	4.52	1.8	1.92	2.68	2.59	Upgrade
Operating Income	-11.46	-27.53	-12.13	-15.14	-3.94	-4.52	-1.8	-1.92	-2.69	-2.55	Upgrade
Interest Expense / Income	0	0	0	0.28	0.04	0.16	0.06	0	0.24	0.32	Upgrade
Other Expense / Income	-0.34	-0.1	-0.18	-0	-0.01	-0.02	-0.01	-0	0.43	1.66	Upgrade
Pretax Income	-11.12	-27.42	-11.96	-15.41	-3.96	-4.67	-1.86	-1.92	-3.35	-4.53	Upgrade
Income Tax	0	0	-0.53	-1	-0.6	-0.9	0	0	0	0	Upgrade
Net Income	-11.12	-27.42	-11.43	-14.41	-3.36	-3.77	-1.86	-1.92	-3.35	-4.53	Upgrade
Preferred Dividends	0	0	0	0	0	0	0	0	0.04	1.5	Upgrade
Net Income Common	-11.12	-27.42	-11.43	-14.41	-3.36	-3.77	-1.86	-1.92	-3.4	-6.03	Upgrade
Shares Outstanding (Basic)	1	1	1	0	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	1	1	0	0	0	0	0	0	0	Upgrade
Shares Change	62.83%	5.16%	104.27%	35.72%	3.63%	14.51%	11.17%	1763.81%	24.32%	75.86%	Upgrade
EPS (Basic)	-8.48	-34.05	-15.00	-50.80	-14.00	-14.20	-8.40	-9.80	-303.80	-666.40	Upgrade
EPS (Diluted)	-8.48	-34.05	-15.00	-50.80	-14.00	-14.20	-8.40	-9.80	-303.80	-666.40	Upgrade
Free Cash Flow	-8.07	-9.61	-8.72	-3.14	-2.75	-3.73	-1.68	-2.18	-0.84	-2.7	Upgrade
Free Cash Flow Per Share	-6.15	-11.93	-11.38	-8.38	-9.95	-13.99	-7.20	-10.40	-74.95	-299.01	Upgrade
Gross Margin	-	-	-	-	-	-	-	-	-10.98%	37.68%	Upgrade
Operating Margin	-	-	-	-	-	-	-	-	-2372.57%	-2376.14%	Upgrade
Profit Margin	-	-	-	-	-	-	-	-	-2995.08%	-5622.15%	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-	-	-	-742.52%	-2520.21%	Upgrade
EBITDA	-11.04	-26.55	-11.08	-14.25	-3.05	-3.88	-1.8	-1.92	-2.88	-3.78	Upgrade
EBITDA Margin	-	-	-	-	-	-	-	-	-2538.82%	-3527.33%	Upgrade
Depreciation & Amortization	0.08	0.87	0.88	0.88	0.88	0.63	0	0	0.24	0.43	Upgrade
EBIT	-11.12	-27.42	-11.96	-15.13	-3.92	-4.51	-1.8	-1.92	-3.12	-4.21	Upgrade
EBIT Margin	-	-	-	-	-	-	-	-	-2749.38%	-3926.60%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).